Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
SGMT on Nasdaq
There are no Buy or Sell transactions made by NEW ENTERPRISE ASSOCIATES 13 LP since 13 Feb 2025
Holdings reported by NEW ENTERPRISE ASSOCIATES 13 LP for Sagimet Biosciences Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Series A Common Stock |
3,000,275 |
$12,301,128 |
$4.10 |
29 Jan 2024 |
Direct |
|
|
| Common Stock |
0 |
|
|
18 Jul 2023 |
Direct |
|
|
| Common Stock Warrant (right to buy) |
0 |
|
|
18 Jul 2023 |
Direct |
Common Stock |
|
| Series B-1 Preferred Stock |
0 |
|
|
18 Jul 2023 |
Direct |
Common Stock |
|
| Series B Preferred Stock |
0 |
|
|
18 Jul 2023 |
Direct |
Common Stock |
|
| Series C Preferred Stock |
0 |
|
|
18 Jul 2023 |
Direct |
Common Stock |
|
| Series D Preferred Stock |
0 |
|
|
18 Jul 2023 |
Direct |
Common Stock |
|
| Series E Preferred Stock |
0 |
|
|
18 Jul 2023 |
Direct |
Common Stock |
|
| Series F Preferred Stock |
0 |
|
|
18 Jul 2023 |
Direct |
Common Stock |
|
Transactions reported by NEW ENTERPRISE ASSOCIATES 13 LP for Sagimet Biosciences Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.